LEADER 01444oam  2200457   450 
001 9910555135303321
005 20210617135029.0
010   $a1-119-80823-5
010   $a1-119-80826-X
010   $a1-119-80825-1
035   $a(CKB)4100000011715350
035   $a(MiAaPQ)EBC6452699
035   $a(PPN)260498823
035   $a(EXLCZ)994100000011715350
100   $a20210617d2021      uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aLanguage and neurology $ealzheimer's disease. /$fChristophe Cusimano
210  1$aLondon, England :$cISTE Ltd ;$aHoboken, New Jersey :$cJohn Wiley & Sons, Incorporated,$d[2021]
210  4$d©2021
215   $a1 online resource (197 pages) $cillustrations
311   $a1-78630-662-X 
320   $aIncludes bibliographical references and index.
606   $aPsycholinguistics
606   $aAlzheimer's disease$xPatients$xLanguage
606   $aLanguage disorders$xPathophysiology
615  0$aPsycholinguistics.
615  0$aAlzheimer's disease$xPatients$xLanguage.
615  0$aLanguage disorders$xPathophysiology.
676   $a612.82336
700   $aCusimano$b Christophe$01217416
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bUtOrBLW
906   $aBOOK
912   $a9910555135303321
996   $aLanguage and neurology$92815494
997   $aUNINA